Importance of antifungal prophylaxis in patients who received a nonmyeloablative allogeneic PBSC transplant.
Mossad
Sherif B
SB
Department of Infectious Diseases, Cleveland Clinic Foundation, Cleveland, OH, 44195, USA. mossads@ccf.org
Avery
Robin K
RK
Bolwell
Brian J
BJ
D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use*; D018890:Chemoprevention; D015725:Fluconazole / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D017964:Itraconazole / Q000627:therapeutic use; D009181:Mycoses / Q000517:prevention & control*; D011183:Postoperative Complications / Q000517:prevention & control*; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous
D000935:Antifungal Agents; D017964:Itraconazole; D000666:Amphotericin B; D015725:Fluconazole